| Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol P Lesueur, J Lequesne, JM Grellard, A Dugué, E Coquan, PE Brachet, ... BMC cancer 19, 1-11, 2019 | 120 | 2019 |
| O6‐methylguanine‐DNA methyltransferase (MGMT) promoter methylation and low MGMT‐encoded protein expression as prognostic markers in glioblastoma patients treated with … E Lechapt‐Zalcman, G Levallet, AE Dugué, A Vital, MD Diebold, P Menei, ... Cancer 118 (18), 4545-4554, 2012 | 109 | 2012 |
| Scar extent evaluated by late gadolinium enhancement CMR: a powerful predictor of long term appropriate ICD therapy in patients with coronary artery disease J Alexandre, E Saloux, AE Dugué, A Lebon, A Lemaitre, V Roule, ... J Cardiovasc Magn Reson 15, 12, 2013 | 81 | 2013 |
| Staging the axilla in breast cancer patients with 18F-FDG PET: how small are the metastases that we can detect with new generation clinical PET systems? D Bellevre, C Blanc Fournier, O Switsers, AE Dugué, C Levy, D Allouache, ... European journal of nuclear medicine and molecular imaging 41, 1103-1112, 2014 | 64 | 2014 |
| REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumours C Levy, D Allouache, J Lacroix, AE Dugué, S Supiot, M Campone, ... Annals of Oncology 25 (12), 2351-2356, 2014 | 63 | 2014 |
| Vascular access sites for acute renal replacement in intensive care units AE Dugué, SP Levesque, MO Fischer, B Souweine, JP Mira, ... Clinical Journal of the American Society of Nephrology 7 (1), 70-77, 2012 | 61 | 2012 |
| Continuous renal replacement therapy may increase the risk of catheter infection JJ Parienti, AE Dugué, C Daurel, JP Mira, B Mégarbane, LA Mermel, ... Clinical Journal of the American Society of Nephrology 5 (8), 1489-1496, 2010 | 58 | 2010 |
| Fatigue is associated with metabolic and density alterations of cortical and deep gray matter in Relapsing-Remitting-Multiple Sclerosis patients at the earlier stage of the … N Derache, B Grassiot, F Mézenge, A Emmanuelle Dugué, B Desgranges, ... Multiple Sclerosis and Related Disorders 2 (4), 362-369, 2013 | 55 | 2013 |
| Viral epidemiology and severity of respiratory infections in infants in 2009: a prospective study C Laurent, AE Dugué, J Brouard, D Nimal, J Dina, JJ Parienti, A Vabret The Pediatric infectious disease journal 31 (8), 827-831, 2012 | 48 | 2012 |
| Alterations of left ventricular myocardial strain in obese children F Labombarda, E Zangl, AE Dugue, D Bougle, A Pellissier, V Ribault, ... European Heart Journal–Cardiovascular Imaging 14 (7), 668-676, 2013 | 44 | 2013 |
| Diagnostic value of three-dimensional contrast-enhanced echocardiography for left ventricular volume and ejection fraction measurement in patients with poor acoustic windows: a … E Saloux, F Labombarda, A Pellissier, B Anthune, AE Dugué, N Provost, ... Journal of the American Society of Echocardiography 27 (10), 1029-1040, 2014 | 37 | 2014 |
| Rotational atherectomy for left main coronary artery disease in octogenarians: transradial approach in a tertiary center and literature review Z Dahdouh, V Roule, AE Dugue, R Sabatier, T Lognone, G Grollier Journal of interventional cardiology 26 (2), 173-182, 2013 | 37 | 2013 |
| Identification of predictive factors of response to the BH3‐mimetic molecule ABT‐737: An ex vivo experiment in human serous ovarian carcinoma S Lheureux, M N'Diaye, C Blanc‐Fournier, AE Dugué, B Clarisse, S Dutoit, ... International journal of cancer 136 (5), E340-E350, 2015 | 33 | 2015 |
| Predictive factors for lateral occult lymph node metastasis in papillary thyroid carcinoma V Patron, M Hitier, C Bedfert, A Métreau, A Dugué, F Jegoux European Archives of Oto-Rhino-Laryngology 270, 2095-2100, 2013 | 30 | 2013 |
| Long-term results of 81 prevertebral subclavian artery angioplasties: a 26-year experience L Berger, Z Bouziane, A Felisaz, O Coffin, A Dugue, D Maiza Annals of Vascular Surgery 25 (8), 1043-1049, 2011 | 28 | 2011 |
| Renal insufficiency is the leading cause of double maintenance (bevacizumab and pemetrexed) discontinuation for toxicity to advanced non-small cell lung cancer in real world … M Sassier, AE Dugué, B Clarisse, P Lesueur, V Avrillon, ... Lung Cancer 89 (2), 161-166, 2015 | 23 | 2015 |
| Scar extent as a predictive factor of ventricular tachycardia cycle length after myocardial infarction: implications for implantable cardioverter-defibrillator programming … J Alexandre, E Saloux, A Lebon, AE Dugué, A Lemaitre, V Roule, ... Europace, eut289, 2013 | 23 | 2013 |
| Utility of serum anti‐cetuximab immunoglobulin E levels to identify patients at a high risk of severe hypersensitivity reaction to cetuximab B Dupont, D Mariotte, AE Dugué, B Clarisse, JM Grellard, E Babin, ... British Journal of Clinical Pharmacology 83 (3), 623-631, 2017 | 21 | 2017 |
| How to improve the prevention of chemotherapy-induced nausea and vomiting? The French NAVI study J Vanbockstael, E Coquan, S Gouerant, D Allouache, A Faveyrial, S Noal, ... Supportive Care in Cancer 24, 1131-1138, 2016 | 19 | 2016 |
| How to deal with interval-censored data practically while assessing the progression-free survival: a step-by-step guide using SAS and R software AE Dugué, M Pulido, S Chabaud, L Belin, J Gal Clinical Cancer Research 22 (23), 5629-5635, 2016 | 15 | 2016 |
